RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 3.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,435 | -35.4% | 10,395 | -70.4% | 0.00% | – |
| Q1 2023 | $30,100 | +58.4% | 35,154 | +234.5% | 0.00% | – |
| Q2 2020 | $19,000 | +11.8% | 10,510 | 0.0% | 0.00% | – |
| Q1 2020 | $17,000 | -22.7% | 10,510 | +1.0% | 0.00% | – |
| Q4 2019 | $22,000 | +10.0% | 10,410 | -0.5% | 0.00% | – |
| Q3 2019 | $20,000 | -25.9% | 10,465 | 0.0% | 0.00% | – |
| Q2 2019 | $27,000 | -3.6% | 10,465 | -3.7% | 0.00% | – |
| Q1 2019 | $28,000 | +3.7% | 10,865 | -15.5% | 0.00% | – |
| Q4 2018 | $27,000 | -20.6% | 12,865 | +7.2% | 0.00% | – |
| Q3 2018 | $34,000 | +21.4% | 12,000 | +20.0% | 0.00% | – |
| Q2 2018 | $28,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2018 | $35,000 | -10.3% | 10,000 | -1.0% | 0.00% | – |
| Q4 2017 | $39,000 | +56.0% | 10,100 | +1.0% | 0.00% | – |
| Q3 2017 | $25,000 | -7.4% | 10,000 | 0.0% | 0.00% | – |
| Q2 2017 | $27,000 | -18.2% | 10,000 | 0.0% | 0.00% | – |
| Q1 2017 | $33,000 | +37.5% | 10,000 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -35.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2016 | $37,000 | +68.2% | 10,000 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | +4.8% | 10,000 | 0.0% | 0.00% | – |
| Q1 2016 | $21,000 | -30.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2015 | $30,000 | +20.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2015 | $25,000 | -21.9% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $32,000 | -11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $36,000 | +56.5% | 10,000 | 0.0% | 0.00% | – |
| Q4 2014 | $23,000 | +21.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2014 | $19,000 | -47.2% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $36,000 | -7.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $39,000 | +34.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $29,000 | -19.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $36,000 | +9.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $33,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |